TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
Clinical trial NCT05894421 · UNKNOWN
Trial details
- NCT number
- NCT05894421
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-06
- Primary completion
- 2025-01-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.